Skip to main content
Equibles

Tony Wren

Analyst

Macquarie

Equibles does not estimate personal net worth.

About Tony Wren

Tony Wren is recorded as Analyst at Macquarie. Tony Wren has spoken on 1 earnings call across 1 company, most recently for Takeda Pharmaceutical Co Ltd on May 13, 2026. The companies whose calls Tony Wren spoke on are classified in the Healthcare sector.

Tony Wren on recent calls

“The first question is about the clinical development program for your thinking about Zasocitinib in IBD. Recently, one of your competitors conducted a couple of phase two trials, testing a combination of interleukin-23 and TNF-alpha agents together in both Crohn's and Colitis.”
Analyst — Macquarie, Earnings conference call (announced in 6-K) ·

Affiliation history

  • Macquarie

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity